SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 290,828.77 |
| Enterprise Value ($M) | 337,689.77 |
| Book Value ($M) | 12,129.00 |
| Book Value / Share | 6.85 |
| Price / Book | 23.98 |
| NCAV ($M) | -91,312.00 |
| NCAV / Share | -51.57 |
| Price / NCAV | -3.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.76 |
| Current Ratio | 0.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 33,002.00 |
| Assets | 134,711.00 |
| Liabilities | 124,314.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54,318.00 |
| Operating Income | 17,425.00 |
| Net Income | 4,863.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 22,839.00 |
| Cash from Investing | -2,009.00 |
| Cash from Financing | -17,222.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.08 | 1.30 | |
| 13G/A | BlackRock Inc. | 8.10 | 3.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 769,120 | 3,649,333 | 21.08 | |
| 680,110 | 2,990,420 | 22.74 | |
| 913,604 | 3,425,552 | 26.67 | |
| 562,929 | 5,433,730 | 10.36 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABT – Abbott Laboratories | ADCT – ADC Therapeutics SA |